​Cwestiynau Ysgrifenedig y Cynulliad a gyflwynwyd ar 9 Mehefin 2016 i'w hateb ar 16 Mehefin 2016

R - Yn dynodi bod yr Aelod wedi datgan buddiant.
W - Yn dynodi bod y cwestiwn wedi'i gyflwyno yn Gymraeg.

(Dangosir rhif gwreiddiol y Cwestiwn mewn cromfachau)

Mae'n rhaid cyflwyno Cwestiynau Ysgrifenedig o leiaf bum diwrnod gwaith cyn y maent i gael eu hateb.  Yn ymarferol, bydd Gweinidogion yn ceisio ateb o fewn saith neu wyth diwrnod ond nid oes rheidrwydd arnynt i wneud hynny. Caiff yr atebion eu cyhoeddi yn yr iaith y maent yn cael eu darparu, gyda chyfieithiad i'r Saesneg o ymatebion a ddarperir yn Gymraeg.

Gofyn i Ysgrifennydd y Cabinet dros Iechyd, Llesiant a Chwaraeon

Janet Finch-Saunders (Aberconwy): Pa asesiad y mae'r Gweinidog wedi'i wneud o'r effaith y byddai cynnydd yn nifer y menywod dros 50 sy'n dewis cael prawf sgrinio serfigol yn ei chael ar yr achosion o ganser serfigol yn y grŵp oedran hwn? (WAQ70389)

Derbyniwyd ateb ar 16 Mehefin 2016

Ysgrifennydd y Cabinet dros Iechyd, Llesiant a Chwaraeon(Vaughan Gething): Cervical cancer screening has a significant impact on reducing cervical cancer incidence and incidence rates have fallen considerably since the inception of Cervical Screening Wales. A recent report by Cancer Research UK (CRUK) estimated the incidence of invasive cervical cancer in women aged 50-64 in Wales would be nearly four times higher were it not for the screening programme.

Janet Finch-Saunders (Aberconwy): Pa asesiad y mae'r Gweinidog wedi'i wneud o'r hyn sy'n rhwystro menywod dros 50 rhag mynd i gael prawf sgrinio serfigol? (WAQ70390)

Derbyniwyd ateb ar 16 Mehefin 2016

Vaughan Gething:  The Screening Engagement team of Public Health Wales is working with local Public Health Teams, Health Boards and Primary Care clusters to consider cervical screening uptake in each region and plan specific activities to improve uptake.

Cervical screening remains a priority for the Welsh Government, as demonstrated by the implementation of Human Papillomavirus (HPV) test of cure* across Wales over the last 18 months and the roll out of HPV triage** from May 2016. These developments will result in fewer colposcopies and repeat smears being undertaken, and as a consequence we anticipate this will have a positive impact on uptake rates. 

*Women who have had treatment for abnormal smears are now tested for HPV when they have a follow up smear six months later. If the HPV test is negative they will be called for a smear again in three years, rather than being invited back for colposcopy or annual follow up smears (which could have continued for up to 10 years).
 
**Women who have a low grade abnormality on their smear currently have two or three repeat smears before being either referred to colposcopy or returned to normal recall. Adding a HPV test to the first abnormal smear will identify women who need immediate referral and those who can safely remain on normal recall.

Janet Finch-Saunders (Aberconwy): Pa drafodaethau y mae'r Gweinidog wedi'u cael â chyrff iechyd y cyhoedd i gynyddu nifer y menywod dros 50 sy'n dewis cael prawf sgrinio serfigol? (WAQ70391)

Derbyniwyd ateb ar 16 Mehefin 2016

Vaughan Gething: Coverage of cervical screening across Wales is very close to the target of 80%. Overall coverage rates in 2014/15 saw a slight drop (78% in 2014/15 from 78.4% in 2013-14), in line with the trend seen in other countries. Participation among the over 50s remains high. Coverage for women aged 50-64 was 76.3% in 2014/15 compared to 76.8% in 2013/14.
We know that cervical screening saves lives and we have tasked Public Health Wales, who are responsible for the delivery of the national population screening programmes in Wales, to meet and exceed the performance targets set for Cervical Screening Wales.
As an NHS Trust, Public Health Wales is part of the wider NHS planning and performance system and the organisation’s delivery framework and Integrated Medium Term Plan include key actions and service performance indicators for Cervical Screening Wales.
Performance is scrutinised on a number of levels, including periodic ministerial meetings with the Chair of Public Health Wales, bi-annual joint executive team meetings between Welsh Government and Public Health Wales’ executives and more frequent meetings with policy officials.

Janet Finch-Saunders (Aberconwy): A wnaiff Llywodraeth Cymru amlinellu beth oedd cyfradd yr achosion o ganser serfigol ar gyfer menywod dros 50 yn ystod pob un o'r 10 mlynedd diwethaf y mae'r data ar gael? (WAQ70392)

Derbyniwyd ateb ar 16 Mehefin 2016

Vaughan Gething:  The Welsh Cancer Intelligence and Surveillance Unit (WCISU) is the National Cancer Registry for Wales. It records, stores and reports on all incidence of cancer for the resident population of Wales wherever they are treated. I attach a link to the WCISU website, which contains both data tables and interactive tools on cervical cancer incidence: http://www.wcisu.wales.nhs.uk/home

Gofyn i Ysgrifennydd y Cabinet dros Gyllid a Llywodraeth Leol

Janet Finch-Saunders (Aberconwy): Pa drafodaethau y mae'r Gweinidog wedi'u cael â Llywodraeth y DU ynghylch nifer y bobl a bleidleisiodd yn etholiad Cynulliad Cymru ac, yn benodol, y nifer isel o bobl a bleidleisiodd yn Alun a Glannau Dyfrdwy? (WAQ70388)

Derbyniwyd ateb ar 14 Mehefin 2016

Ysgrifennydd y Cabinet dros Gyllid a Llywodraeth Leol (Mark Drakeford): I have not held any discussions with the UK Government regarding voter turnout. The Electoral Commission has a duty to report on all elections and will produce a report on the 2016 Welsh Assembly elections including voters’ experience.